TY - JOUR
T1 - Enhancers predominantly regulate gene expression during differentiation via transcription initiation
AU - Larke, Martin S.C.
AU - Schwessinger, Ron
AU - Nojima, Takayuki
AU - Telenius, Jelena
AU - Beagrie, Robert A.
AU - Downes, Damien J.
AU - Oudelaar, A. Marieke
AU - Truch, Julia
AU - Graham, Bryony
AU - Bender, M. A.
AU - Proudfoot, Nicholas J.
AU - Higgs, Douglas R.
AU - Hughes, Jim R.
N1 - Funding Information:
We thank S. Butler, J. Sloane-Stanley, and J. Sharpe of the WIMM Transgenics Facility; K. Clark, S.-A. Clark, and C. Waugh of the WIMM Flow Cytometry Facility; and the MRC WIMM Centre for Computational Biology.This work was supported by the Medical Research Council (grants MC_UU_0009/4 and MR/T014067/1 to D.R.H. and grant MC_UU_00016/14 to J.R.H.), a Wellcome Trust Strategic Award (106130/Z/14/Z to D.R.H. and J.R.H.), an ERC advanced grant (339270) and Wellcome Trust Investigator Award (107928|Z|15|Z) (to T.N. and N.J.P.), a Stevenson Junior Research Fellowship at University College, Oxford (to A.M.O.), and a Sir Henry Wellcome postdoctoral fellowship (209181/Z/17/Z to R.A.B.). M.A.B. was supported by NIH grant R37 DK44746 to M. Groudine. Funding, J.R.H. D.R.H. and M.S.C.L.; Conceptualization, J.R.H. D.R.H. and M.S.C.L.; Methodology, M.S.C.L. and J.R.H.; Validation, M.S.C.L.; Formal Analysis, R.S. J. Telenius, and R.A.B.; Investigation, M.S.C.L. (T.N. performed mNET-seq, and D.J.D. performed NG-Capture-C); Software, J. Telenius, R.A.B. R.S. and A.M.O; Writing, M.S.C.L. D.R.H. and J.R.H. with N.J.P. M.A.B, R.A.B. A.M.O. and D.J.D.; Visualization, M.S.C.L. J.R.H. and D.R.H.; Data Curation, M.S.C.L.; Supervision, J.R.H. and D.R.H.; Project Administration, M.S.C.L. J.R.H. and D.R.H. J.R.H. is a founder and director of Nucleome Therapeutics.
Funding Information:
We thank S. Butler, J. Sloane-Stanley, and J. Sharpe of the WIMM Transgenics Facility; K. Clark, S.-A. Clark, and C. Waugh of the WIMM Flow Cytometry Facility; and the MRC WIMM Centre for Computational Biology.This work was supported by the Medical Research Council (grants MC_UU_0009/4 and MR/T014067/1 to D.R.H. and grant MC_UU_00016/14 to J.R.H.), a Wellcome Trust Strategic Award ( 106130/Z/14/Z to D.R.H., and J.R.H.), an ERC advanced grant (339270) and Wellcome Trust Investigator Award ( 107928|Z|15|Z ) (to T.N. and N.J.P.), a Stevenson Junior Research Fellowship at University College, Oxford (to A.M.O.), and a Sir Henry Wellcome postdoctoral fellowship ( 209181/Z/17/Z to R.A.B.). M.A.B. was supported by NIH grant R37 DK44746 to M. Groudine.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/3/4
Y1 - 2021/3/4
N2 - Gene transcription occurs via a cycle of linked events, including initiation, promoter-proximal pausing, and elongation of RNA polymerase II (Pol II). A key question is how transcriptional enhancers influence these events to control gene expression. Here, we present an approach that evaluates the level and change in promoter-proximal transcription (initiation and pausing) in the context of differential gene expression, genome-wide. This combinatorial approach shows that in primary cells, control of gene expression during differentiation is achieved predominantly via changes in transcription initiation rather than via release of Pol II pausing. Using genetically engineered mouse models, deleted for functionally validated enhancers of the α- and β-globin loci, we confirm that these elements regulate Pol II recruitment and/or initiation to modulate gene expression. Together, our data show that gene expression during differentiation is regulated predominantly at the level of initiation and that enhancers are key effectors of this process. Larke et al. use a modification of Start-seq (scaRNA-seq) to simultaneously quantify initiation and pausing. Combined with nascent transcription assays, they show that initiation is the predominant point of transcriptional control during differentiation. Specific enhancer deletions cause loss of Pol II recruitment or initiation rather than affecting Pol II pausing.
AB - Gene transcription occurs via a cycle of linked events, including initiation, promoter-proximal pausing, and elongation of RNA polymerase II (Pol II). A key question is how transcriptional enhancers influence these events to control gene expression. Here, we present an approach that evaluates the level and change in promoter-proximal transcription (initiation and pausing) in the context of differential gene expression, genome-wide. This combinatorial approach shows that in primary cells, control of gene expression during differentiation is achieved predominantly via changes in transcription initiation rather than via release of Pol II pausing. Using genetically engineered mouse models, deleted for functionally validated enhancers of the α- and β-globin loci, we confirm that these elements regulate Pol II recruitment and/or initiation to modulate gene expression. Together, our data show that gene expression during differentiation is regulated predominantly at the level of initiation and that enhancers are key effectors of this process. Larke et al. use a modification of Start-seq (scaRNA-seq) to simultaneously quantify initiation and pausing. Combined with nascent transcription assays, they show that initiation is the predominant point of transcriptional control during differentiation. Specific enhancer deletions cause loss of Pol II recruitment or initiation rather than affecting Pol II pausing.
UR - http://www.scopus.com/inward/record.url?scp=85101291818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101291818&partnerID=8YFLogxK
U2 - 10.1016/j.molcel.2021.01.002
DO - 10.1016/j.molcel.2021.01.002
M3 - Article
C2 - 33539786
AN - SCOPUS:85101291818
SN - 1097-2765
VL - 81
SP - 983-997.e7
JO - Molecular Cell
JF - Molecular Cell
IS - 5
ER -